News Conference News TCT 2022 Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test Shelley Wood September 18, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2021 Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support Caitlin E. Cox November 11, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News TCT 2021 Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On Caitlin E. Cox November 09, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News TCT 2021 Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More Todd Neale November 04, 2021
News Conference News TCT 2021 Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints Todd Neale November 04, 2021
News Opinion Editor's Corner TCT 2021 In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More Shelley Wood November 01, 2021
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Conference News TCT 2020 Treating Accessory Arteries May Be Important in Renal Denervation Todd Neale October 18, 2020
News Conference News TCT 2020 Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves Todd Neale October 17, 2020
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
Presentation TCT 2020 OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES Presenter: Dean Kereiakes October 17, 2020
Presentation TCT 2020 COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients Presenter: Robert Byrne October 17, 2020
Presentation TCT 2020 HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes Presenter: Hyo-Soo Kim October 17, 2020
News Conference News TCT 2020 Stent Polymer Face-off Calls Bioresorbable Coatings Into Question Shelley Wood October 17, 2020
Presentation TCT 2020 What Clinical Trials Are Needed to Support MCS in the Modern Era? Presenter: Gregg Stone October 16, 2020